Type 2s on Sulfonylureas Less Likely to Take Anti-Depressants

Diabetes Health Staff

Jun 1, 2011

Sulfonylureas and Depression

Type 2 patients who use only a sulfonylurea are less likely to take anti-depressant drugs than diabetes patients on other medications. That's the conclusion of a report delivered recently in Honolulu at the annual meeting of the American Psychiatric Association.

The report, which summarized a retrospective study by a Norwegian researcher, said that diabetes patients taking a sulfonylurea as their only disease medication had the lowest likelihood of also being prescribed an antidepressant. The researcher, Øivind Hundal, MPharm, PhD, of Haukeland University Hospital in Bergen, theorized that the insulin-inducing properties of sulfonylureas may have an antidepressant effect on the brain, thus doing away with the need for other antidepressants.

Hundal had previously theorized that depression might be a form of "diabetes of the brain," in which high cerebral glucose levels affect brain function and moods.

Hundal's research team analyzed data from 3.4 million adult patients to see how the number of antidepressant prescriptions matched with the types of diabetes medications they were taking. Those medications included sulfonylureas, biguanides, and thiazolidinediones. After studying the data, Hundal concluded that sulfonylureas appeared to have a direct and beneficial effect on depression.

First developed in the 1950s, sulfonylureas are a class of drugs that work by stimulating insulin production in pancreatic beta cells. For years, the drugs were the first ones doctors and endocrinologists would prescribe to newly diagnosed type 2 patients. These days, a later drug, metformin, is often the drug first prescribed, partly because of its greater effect on overweight people.

Hundal's findings suggest only a connection between insulin levels and depression, not causation. The hope is that further study could reveal ways to create more effective antidepressant drugs.

Categories: Depression, Diabetes, Diabetes, Metformin, Sulfonylureas, Type 1 Issues, Type 2 Issues

Comments

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Registered User Anonymous

Your Name:	Your Email:	X

Recipient's Name:	Recipient's Email:

Your Chosen Username:	Your Email Address:

Chosen Password:	Confirm Password:

Email to a Friend

Type 2s on Sulfonylureas Less Likely to Take Anti-Depressants

You May Also Be Interested In...

Comments

Register...

Have Your Say...

Diabetes Health

Topics

Topics

Topics

Diabetes Health Medical Disclaimer

Comment: